Human CIF130 polypeptides
US6423822B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 9, 2000 |
| Grant date | Jul 23, 2002 |
| Priority date | — |
| Expiry date | Nov 9, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A human gene termed CIF130 and its expression products can alter the spatial or temporal patterns of mitosis or cell cycle progression of a human cell. Methods of treating disorders involving alterations in the regulation of mitosis or cell cycle progression utilize the gene and its expression product. Genes whose expression is dependent upon CIF130 expression can be identified.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.